By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Sequenom reported after the close of the market on Tuesday that total revenues for the fourth quarter rose 28 percent on higher system and consumables sales.

Sequenom Chairman and CEO Harry Hixson also said that a nearly two-year old investigation by the US Securities and Exchange Commission may be coming to an end and the agency may bring civil injunction action against the firm.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Helix customers can purchase apps that interpret different aspects of their genome, Technology Review reports.

The New York Times reports that a number of companies and research institutes are pursuing gene therapies.

Salmon with shorter telomeres survive to make the trip back to their river homes, New Scientist reports.

In PLOS this week: vaginal microbiome composition, population patterns of Chagas-carrying Rhodnius ecuadoriensis, and more.